ASX:ACL

Australian Clinical Labs Limited · ASX · Healthcare · AUD · FY for 2026

Figures on this page computed 2026-11-08 13:00 UTC

Last close

n/aAUD

Market data

27.0xP/E
Price / Earnings per Share (diluted)
Source
computed
Taken on
2026-11-08
Reported in
AUD
- computed
- Computed from the filing for 2026
8.6%ROIC
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
Source
computed
Taken on
2026-11-08
Reported in
AUD
- Computed from the filing for 2026
- Computed from the filing for 2026
- Computed from the filing for 2026
- Computed from the filing for 2026
- Computed from the filing for 2026
- Computed from the filing for 2026
3.3%Net margin
Net Income / Revenue x 100
Source
computed
Taken on
2026-11-08
Reported in
AUD
- Computed from the filing for 2026
- Computed from the filing for 2026
21.1%FCF margin
Free Cash Flow / Revenue x 100
Source
computed
Taken on
2026-11-08
Reported in
AUD
- Computed from the filing for 2026
- Computed from the filing for 2026
2.26Debt/equity
Total Debt / Shareholders' Equity
Source
computed
Taken on
2026-11-08
Reported in
AUD
- Computed from the filing for 2026
- Computed from the filing for 2026
4.0%Dividend yield
Source
computed
Taken on
2026-11-08
Reported in
AUD
- computed

Safety is the furthest below its sector's middle: 0.29 against 0.57 on the market's range.

All from 100

lens 2 of 9

Sales

215

2017-06-30 to 2026-06-30100 at the start215

Sales: 100.00 on 2017-06-30 to 214.71 on 2026-06-30, up 115%.

Shares in issue

95.1

2017-06-30 to 2026-06-30100 at the start95.1

Shares in issue: 100.00 on 2017-06-30 to 95.08 on 2026-06-30, down 5%.

Profit, where the first year is 100: n/aNot enough filed years carry this line for it to be drawn. No line is drawn flat in its place.

Sales is at 215, Shares in issue is at 95, against 100 in 2017.

Sales is at 215, Shares in issue is at 95, against 100 in 2017.

Every figure in this lens

Except where said otherwise: Computed from the filing for 2026

Sales, where the first year is 100215
Source
computed
Statement
income
Fiscal year
2026
Reported in
AUD
Profit, where the first year is 100n/a
Not held.
Source
computed
Statement
income
Fiscal year
2026
Reported in
AUD
Shares in issue, where the first year is 10095
Source
computed
Statement
income
Fiscal year
2026
Reported in
AUD